A Preliminary Study to Evaluate the Immune Response to a Booster Dose of the Adult Tetanus-Diphtheria Vaccine (Td) Available in Iran.

Journal: Iranian journal of pharmaceutical research : IJPR
Published Date: Sep 11, 2024

Abstract

BACKGROUND: Despite the availability of tetanus-diphtheria (TD) vaccines in Iran, the seroconversion rate of these products as a booster dose is unknown.

Authors

  • Sepideh Noorian
    Department of Pharmacognosy and Pharmaceutical Biotechnology, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran.
  • Negar Mottaghi-Dastjerdi
    Department of Pharmacognosy and Pharmaceutical Biotechnology, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran.
  • Mohammad Soltany-Rezaee-Rad
    Behestan Innovation Factory, Behestan Darou, Tehran, Iran.
  • Hamed Montazeri
    Department of Pharmacognosy and Pharmaceutical Biotechnology, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran.
  • Masoumeh Baghaei
    Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Mohammad-Javad Niazi
    Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals